Kiniksa Pharmaceuticals International KNSA SEC Filings

NASDAQ KNSA
$79.96 +2.87 (+3.72%)
As of: Sep 9, 2026 · 11:53 AM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Kiniksa Pharmaceuticals International, plc (KNSA) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index